| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |